Cargando…

Antibody response after second BNT162b2 dose in allogeneic HSCT recipients

Detalles Bibliográficos
Autores principales: Redjoul, Rabah, Le Bouter, Anne, Beckerich, Florence, Fourati, Slim, Maury, Sébastien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277189/
https://www.ncbi.nlm.nih.gov/pubmed/34270933
http://dx.doi.org/10.1016/S0140-6736(21)01594-4
_version_ 1783722030097498112
author Redjoul, Rabah
Le Bouter, Anne
Beckerich, Florence
Fourati, Slim
Maury, Sébastien
author_facet Redjoul, Rabah
Le Bouter, Anne
Beckerich, Florence
Fourati, Slim
Maury, Sébastien
author_sort Redjoul, Rabah
collection PubMed
description
format Online
Article
Text
id pubmed-8277189
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-82771892021-07-14 Antibody response after second BNT162b2 dose in allogeneic HSCT recipients Redjoul, Rabah Le Bouter, Anne Beckerich, Florence Fourati, Slim Maury, Sébastien Lancet Correspondence Elsevier Ltd. 2021 2021-07-13 /pmc/articles/PMC8277189/ /pubmed/34270933 http://dx.doi.org/10.1016/S0140-6736(21)01594-4 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Redjoul, Rabah
Le Bouter, Anne
Beckerich, Florence
Fourati, Slim
Maury, Sébastien
Antibody response after second BNT162b2 dose in allogeneic HSCT recipients
title Antibody response after second BNT162b2 dose in allogeneic HSCT recipients
title_full Antibody response after second BNT162b2 dose in allogeneic HSCT recipients
title_fullStr Antibody response after second BNT162b2 dose in allogeneic HSCT recipients
title_full_unstemmed Antibody response after second BNT162b2 dose in allogeneic HSCT recipients
title_short Antibody response after second BNT162b2 dose in allogeneic HSCT recipients
title_sort antibody response after second bnt162b2 dose in allogeneic hsct recipients
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277189/
https://www.ncbi.nlm.nih.gov/pubmed/34270933
http://dx.doi.org/10.1016/S0140-6736(21)01594-4
work_keys_str_mv AT redjoulrabah antibodyresponseaftersecondbnt162b2doseinallogeneichsctrecipients
AT lebouteranne antibodyresponseaftersecondbnt162b2doseinallogeneichsctrecipients
AT beckerichflorence antibodyresponseaftersecondbnt162b2doseinallogeneichsctrecipients
AT fouratislim antibodyresponseaftersecondbnt162b2doseinallogeneichsctrecipients
AT maurysebastien antibodyresponseaftersecondbnt162b2doseinallogeneichsctrecipients